Skip to main content
. 2013 Apr 15;7:77–90. doi: 10.2147/BTT.S43628

Table 2.

Adverse events with second line single agent cetuximab in squamous cell carcinoma of the head and neck

All grades Grade 3–4
Dermatological
 Rash 49% 1%
 Acne 26% 0%
 Dry skin 14% 0%
 Nail disorder 16% 0%
Other
 Fever 14% 1%
 Nausea 13% 1%
 Vomiting 11% 2%
 Dyspnea 5% 4%
 Infusion-related reactions 6% 1%